← Leaderboards
Jasmine A Luzum
University Of Michigan At Ann Arbor
$1,392,287
Attributed
$1,392,287
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $619.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,392,287 · 2
By mechanism
K08$772,405 · 1
R01$619,882 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Kenneth A Jamerson$2,889,933
- Alan P Boyle$9,857,541
- Barry E Bleske$493,118
- Reshma Jagsi$6,831,946
- Yuqing E Chen$44,993,151
Others in their field
Other Emerging Leaders on “Registries”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$64,693,871
- Christopher Barnaby Nelson · University Of Melbourne$26,782,982
- Bronwen Shaw · Medical College Of Wisconsin$19,560,999
- Jessica Brooke Langbaum · Banner Health$13,976,144
- Van My Ta Park · University Of Pennsylvania$12,581,552
- Hilal Maradit Kremers · Mayo Clinic Rochester$11,548,597
Research focus
RegistriesMichiganHeart FailurePharmacotherapyPathway InteractionsClinical TrialsGenetic VariantHealth SystemMissionPatient ResponseValidationUnited States National Institutes Of HealthAmericanData SetEnrollmentGeneticGenomic DataGenomicsImproved OutcomeDiabetes MellitusBiological FactorsBiologicalDatabasesEfrac
Grant awards (6)
Personalizing Heart Failure Treatment with Genomics: A Clinical Trial to Understand the Mechanisms and Validate a Polygenic Risk Score for Beta-Blocker Response$619,882
R01 · FY2025 · HL · contact PI
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy$152,977
K08 · FY2023 · HL · contact PI
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy$153,726
K08 · FY2022 · HL · contact PI
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy$154,607
K08 · FY2021 · HL · contact PI
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy$155,456
K08 · FY2020 · HL · contact PI
Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy$155,639
K08 · FY2019 · HL · contact PI